MedWatch Safety Alerts
Injected particulate material may result in local inflammation, phlebitis, and/or low-level allergic response.
Bone Graft Substitutes Containing Recombinant Proteins or Synthetic Peptides in Patients Under Age 18: FDA Safety Communication - Reports of Serious Injuries
Risk of excess bone growth, fluid accumulation, inhibited bone healing, and swelling.
Simulated IV Solutions from Wallcur: CDER Statement- FDA's Investigation into Patients being Injected
FDA and the CDC continue to investigate multiple instances of simulated saline solution being administered to patients and to alert health care providers and regulatory officials to raise awareness of the potential risk. Originally Posted 1/14/2015
IV Solutions from Wallcur of San Diego: CDER Statement - FDA Warns Health Care Professionals Not to Inject Patients
UPDATED 01/10/2015 Wallcur Practi-IV solutions bags are recalled.
Prescription and Over-the-Counter (OTC) Pain Medicines: Drug Safety Communication - FDA Review of Possible Risks of Pain Medicine Use During Pregnancy
Pregnant women urged to discuss all medicines with their health care professionals before using them.
Virazole (Ribavirin Powder For Solution) by Valeant Pharmaceutical North America, LLC: Recall- Due to Microbial Contamination
Inhalation of a non-sterile product with microbial contamination into the airways could increase the risk of respiratory infection.
KimVent Microcuff Subglottic Suctioning Endotracheal Tubes by Halyard Health: Class I Recall - Component May Detach During Use
An air leak between cuff and tracheal wall may reduce the amount of air that reaches the lungs. Use of this recalled product could cause serious health risks, including delayed patient treatment, breathing difficulties, and death.